Published in Proc Natl Acad Sci U S A on August 07, 2001
Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A (2005) 3.06
Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A (2005) 2.49
Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics (2008) 2.43
Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog (2008) 1.98
Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun (2007) 1.79
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One (2008) 1.61
Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics (2011) 1.53
Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol (2009) 1.52
MAEBL is essential for malarial sporozoite infection of the mosquito salivary gland. J Exp Med (2002) 1.41
cDNA sequences reveal considerable gene prediction inaccuracy in the Plasmodium falciparum genome. BMC Genomics (2007) 1.35
A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biol (2014) 1.31
Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle. PLoS Pathog (2010) 1.27
Analysis of the Plasmodium and Anopheles transcriptomes during oocyst differentiation. J Biol Chem (2003) 1.26
Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One (2008) 1.25
Plasmodium immunomics. Int J Parasitol (2010) 1.09
Plasmodium sporozoite invasion of the mosquito salivary gland. Curr Opin Microbiol (2009) 0.99
Functional characterization of a redundant Plasmodium TRAP family invasin, TRAP-like protein, by aldolase binding and a genetic complementation test. Eukaryot Cell (2008) 0.98
Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro. Infect Immun (2004) 0.98
Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle. Parasitol Res (2004) 0.97
Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun (2004) 0.96
Serial Analysis of Gene Expression in Plasmodium berghei salivary gland sporozoites. BMC Genomics (2007) 0.89
Novel approaches to identify protective malaria vaccine candidates. Front Microbiol (2014) 0.87
Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls. Parasitology (2012) 0.87
Identification, cloning, expression, and characterization of the gene for Plasmodium knowlesi surface protein containing an altered thrombospondin repeat domain. Infect Immun (2005) 0.84
Targeted disruption of maebl in Plasmodium falciparum. Mol Biochem Parasitol (2005) 0.83
Early transcriptional responses of HepG2-A16 liver cells to infection by Plasmodium falciparum sporozoites. J Biol Chem (2011) 0.83
Effect of chloroquine on gene expression of Plasmodium yoelii nigeriensis during its sporogonic development in the mosquito vector. Malar J (2007) 0.81
Cloning, expression, and immunocharacterization of surface protein containing an altered thrombospondin repeat domain (SPATR) from Plasmodium knowlesi. Malar J (2013) 0.80
Integrative analysis of intraerythrocytic differentially expressed transcripts yields novel insights into the biology of Plasmodium falciparum. Malar J (2003) 0.80
Gene expression changes in the salivary glands of Anopheles coluzzii elicited by Plasmodium berghei infection. Parasit Vectors (2015) 0.79
Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection. Infect Immun (2015) 0.79
De novo transcriptome sequencing and analysis of Coccinella septempunctata L. in non-diapause, diapause and diapause-terminated states to identify diapause-associated genes. BMC Genomics (2015) 0.79
Do mosquitoes transmit the avian malaria-like parasite Haemoproteus? An experimental test of vector competence using mosquito saliva. Parasit Vectors (2016) 0.76
Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way. Wiley Interdiscip Rev RNA (2016) 0.75
Epigenetic regulation of Plasmodium falciparum clonally variant gene expression during development in Anopheles gambiae. Sci Rep (2017) 0.75
A Novel and Conserved Plasmodium Sporozoite Membrane Protein SPELD is Required for Maturation of Exo-erythrocytic Forms. Sci Rep (2017) 0.75
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A (1992) 5.40
TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell (1997) 4.65
The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol (1986) 4.16
Migration of Plasmodium sporozoites through cells before infection. Science (2001) 3.89
Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science (1998) 3.83
Evidence for the shikimate pathway in apicomplexan parasites. Nature (1998) 3.60
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
A central role for P48/45 in malaria parasite male gamete fertility. Cell (2001) 2.73
A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature (1988) 2.70
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol (1989) 2.64
CTRP is essential for mosquito infection by malaria ookinetes. EMBO J (1999) 2.59
Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites. J Cell Biol (1999) 2.43
Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol (1987) 2.19
Gene discovery by EST sequencing in Toxoplasma gondii reveals sequences restricted to the Apicomplexa. Genome Res (1998) 2.14
Gene targeting in malaria parasites. Methods (1997) 2.03
Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A (1992) 2.00
Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis. Mol Microbiol (2001) 1.96
Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase. J Biol Chem (2001) 1.93
Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun (1987) 1.87
The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development. Dev Dyn (2000) 1.86
Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria. Mol Microbiol (2000) 1.84
Targeted disruption of the plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito. J Exp Med (1999) 1.68
Actomyosin motor in the merozoite of the malaria parasite, Plasmodium falciparum: implications for red cell invasion. J Cell Sci (1998) 1.67
A family of chimeric erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A (1998) 1.58
Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruption. Mol Microbiol (2000) 1.48
Preliminary profile of the Cryptosporidium parvum genome: an expressed sequence tag and genome survey sequence analysis. Mol Biochem Parasitol (2000) 1.45
The development of genetic tools for dissecting the biology of malaria parasites. Annu Rev Microbiol (2000) 1.39
Molecular cloning of a gene from Plasmodium falciparum that codes for a protein sharing motifs found in adhesive molecules from mammals and plasmodia. Mol Biochem Parasitol (1995) 1.31
A novel class of unconventional myosins from Toxoplasma gondii. J Mol Biol (1997) 1.24
Analysis of expressed sequence tags from Plasmodium falciparum. Mol Biochem Parasitol (1994) 1.23
Targeting the shikimate pathway in the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (1999) 1.22
Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol Biochem Parasitol (1994) 1.19
Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. Mol Biochem Parasitol (1999) 1.11
Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J Biol Chem (1997) 1.10
Erythrocyte binding protein homologues of rodent malaria parasites. Mol Biochem Parasitol (1997) 1.07
Toxoplasma gondii expressed sequence tags: insight into tachyzoite gene expression. Mol Biochem Parasitol (1996) 1.03
The malaria sporozoite's journey into the liver. Infect Agents Dis (1996) 0.96
Antisporozoite vaccine for malaria: experimental basis and current status. Rev Infect Dis (1989) 0.95
Characterization of myosin-A and myosin-C: two class XIV unconventional myosins from Toxoplasma gondii. Cell Motil Cytoskeleton (1999) 0.94
Identification of the class XIV myosins Pb-MyoA and Py-MyoA and expression in Plasmodium sporozoites. Mol Biochem Parasitol (2001) 0.93
Toxoplasma gondii secretes a calcium-independent phospholipase A(2). Int J Parasitol (2000) 0.86
Signaling during the invasion of host cells by Toxoplasma gondii. FEMS Microbiol Rev (1999) 0.85
Myosin A expressions in sporogonic stages of Plasmodium. Mol Biochem Parasitol (2000) 0.78
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature (1997) 19.08
Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus. Nature (1997) 14.38
A gene map of the human genome. Science (1996) 14.32
Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics (1998) 12.21
Receptors for complement of leukocytes. J Exp Med (1968) 11.57
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
The TIGR Gene Indices: analysis of gene transcript sequences in highly sampled eukaryotic species. Nucleic Acids Res (2001) 8.44
A concise guide to cDNA microarray analysis. Biotechniques (2000) 8.36
More informative abstracts revisited. Ann Intern Med (1990) 8.26
In vitro synthesis of DNA complementary to purified rabbit globin mRNA (RNA-dependent DNA polymerase-reticulocyte-hemoglobin-density gradient centrifugation-oligo(dT) primer). Proc Natl Acad Sci U S A (1972) 7.89
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Use of check lists in assessing the statistical content of medical studies. Br Med J (Clin Res Ed) (1986) 7.42
Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) (1988) 7.41
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Fiber orientation in the canine left ventricle during diastole and systole. Circ Res (1969) 7.01
Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol (1973) 6.60
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med (1977) 6.19
Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med (1972) 6.13
Gene index analysis of the human genome estimates approximately 120,000 genes. Nat Genet (2000) 6.09
Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet (1994) 6.01
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A (1991) 5.60
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
A precursor of globin messenger RNA. J Mol Biol (1976) 5.34
Mortality and hardness of local water-supplies. Lancet (1968) 5.29
Phenological changes reflect climate change in Wisconsin. Proc Natl Acad Sci U S A (1999) 4.99
Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood (1973) 4.99
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med (1982) 4.96
Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med (1980) 4.81
An optimized protocol for analysis of EST sequences. Nucleic Acids Res (2000) 4.80
RESOURCERER: a database for annotating and linking microarray resources within and across species. Genome Biol (2001) 4.79
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66
TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell (1997) 4.65
Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci (2008) 4.24
Paget's disease of bone in 14 British towns. Br Med J (1977) 4.17
Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science (1988) 4.10
Diffuse axonal injury and traumatic coma in the primate. Ann Neurol (1982) 4.08
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (1989) 4.08
Globin messenger-RNA induction during erythroid differentiation of cultured leukemia cells. Proc Natl Acad Sci U S A (1972) 4.02
Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell (2000) 3.97
A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A (1975) 3.97
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
The effects of systemic hypotension upon the human brain. Clinical and neuropathological observations in 11 cases. Brain (1966) 3.92
Incidence and prediction of ischaemic heart-disease in London busmen. Lancet (1966) 3.91
Migration of Plasmodium sporozoites through cells before infection. Science (2001) 3.89
Age, period and cohort models applied to cancer mortality rates. Stat Med (1983) 3.87
Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science (1998) 3.83
Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann Neurol (1982) 3.82
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 3.80
Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76
Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science (1980) 3.71
Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol (1971) 3.71
Ca++-dependent binding of antigen-19 S antibody complexes to macrophages. J Immunol (1969) 3.70
The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol (1989) 3.69
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med (1986) 3.68
Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med (1976) 3.68
Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis (1995) 3.66
Complement receptor is an inhibitor of the complement cascade. J Exp Med (1981) 3.65
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J (1989) 3.65
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature (1987) 3.62
alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology (2007) 3.62
Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg (1997) 3.61
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
The TIGR Gene Indices: clustering and assembling EST and known genes and integration with eukaryotic genomes. Nucleic Acids Res (2005) 3.53
Aortic stenosis. Circulation (1968) 3.49
Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 3.46
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med (1982) 3.42
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41
Patterns of mortality in middle and early old age in the county boroughs of England and Wales. Br J Prev Soc Med (1969) 3.40
Cyclosporine-associated chronic nephropathy. N Engl J Med (1984) 3.39
A novel protein modification pathway related to the ubiquitin system. EMBO J (1998) 3.36
Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation (1996) 3.34
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg (1991) 3.31
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 3.26
Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science (1985) 3.24
Antibody testing in Lyme disease. A comparison of results in four laboratories. JAMA (1990) 3.20
Patients with head injury who talk and die. Lancet (1975) 3.20
Mean velocity of fiber shortening. A simplified measure of left ventricular myocardial contractility. Circulation (1971) 3.19
Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16
Prevalence of gall stones at necropsy in nine British towns: a collaborative study. Br Med J (1979) 3.16
A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell (2001) 3.13
Long term acid suppressing treatment in general practice. BMJ (1994) 3.11
Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med (1983) 3.07